GAMMA Investing’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Sell
10,416
-375
-3% -$77.9K 0.09% 167
2026
Q1
$2.28M Buy
10,791
+628
+6% +$135K 0.11% 165
2025
Q4
$2.09M Buy
10,163
+1,212
+14% +$228K 0.1% 160
2025
Q3
$1.4M Buy
8,951
+328
+4% +$50.7K 0.08% 214
2025
Q2
$1.45M Buy
8,623
+1,619
+23% +$240K 0.09% 192
2025
Q1
$965K Buy
7,004
+1,549
+28% +$197K 0.07% 251
2024
Q4
$645K Buy
5,455
+1,898
+53% +$222K 0.06% 299
2024
Q3
$393K Buy
3,557
+902
+34% +$94.3K 0.04% 388
2024
Q2
$261K Buy
2,655
+799
+43% +$81.4K 0.04% 428
2024
Q1
$208K Buy
1,856
+623
+51% +$67.2K 0.04% 378
2023
Q4
$135K Buy
+1,233
New +$122K 0.04% 428

Other funds holding CAH

GAMMA Investing's CAH Position: Q2 2026 in Review

GAMMA Investing reduced its Cardinal Health (CAH) stake by 3.5% in Q2 2026, selling an estimated $77.9K and leaving 10,416 shares worth $2.47M. The position accounts for 0.09% of the portfolio, ranked #167.

GAMMA Investing first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. 375 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • GAMMA Investing held 10,416 shares of Cardinal Health worth $2.47M as of Q2 2026.
  • GAMMA Investing sold 375 Cardinal Health shares in Q2 2026, an estimated $77.9K.
  • Cardinal Health made up 0.09% of GAMMA Investing's portfolio in Q2 2026, its #167 holding.
  • GAMMA Investing first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • 375 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.